-
Vanguard Health Care ETF (VHT $268.98)
- $268.98 P/E (TTM): 24.74X Cap: $17.50B
- View VHT Profile
- View Questions on VHT
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Intuitive Surgical Inc. (ISRG $450.06)
- $450.06 P/E (TTM): 55.1X Cap: $159.39B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $201.55)
- $201.55 P/E (TTM): 85.89X Cap: $356.49B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $221.32)
- $221.32 P/E (TTM): 20.17X Cap: $532.76B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $948.45)
- $948.45 P/E (TTM): 42.48X Cap: $893.19B
- View LLY Profile
- View Questions on LLY
-
Merck & Company Inc. (MRK $111.38)
- $111.38 P/E (TTM): 15.43X Cap: $275.08B
- View MRK Profile
- View Questions on MRK
-
Harvest Healthcare Leaders Income ETF (HHL $6.75)
- $6.75 P/E (TTM): 23.48X Cap: $1.61B
- View HHL Profile
- View Questions on HHL
-
Vanguard Health Care ETF (VHT $268.98)
- $268.98 P/E (TTM): 24.74X Cap: $17.50B
- View VHT Profile
- View Questions on VHT
-
Teladoc Health Inc. (TDOC $7.25)
- $7.25 Cap: $1.30B
- View TDOC Profile
- View Questions on TDOC
Q: According to portfolio analytics, I'm seriously underweight in Healthcare, something which I should probably correct. Any of these names herein stick out as great buys in healthcare. US or CAD, no difference to me. Thank you.
-
Eli Lilly and Company (LLY $948.45)
- $948.45 P/E (TTM): 42.48X Cap: $893.19B
- View LLY Profile
- View Questions on LLY
-
Novo Nordisk A/S (NVO $46.07)
- $46.07 P/E (TTM): 12.67X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
Vanguard Health Care ETF (VHT $268.98)
- $268.98 P/E (TTM): 24.74X Cap: $17.50B
- View VHT Profile
- View Questions on VHT
-
iShares U.S. Healthcare ETF (IYH $60.42)
- $60.42 P/E (TTM): 24.16X Cap: $2.75B
- View IYH Profile
- View Questions on IYH
Q: I have a > 50% loss on NVO in an RSP, so I'm unable to harvest the tax loss. Do you feel I would break even faster if I, held, sold and bought a US dollar health ETF or LLY? I'm starting to think healthcare ETF, as if I pick the wrong horse, I can end up in the same situation again. What are your recommendations? Healthcare fits in best for my portfolio weightings.
Thanks
Thanks
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $65.48)
- $65.48 P/E (TTM): 26.33X Cap: $482M
- View XHC Profile
- View Questions on XHC
-
State Street Health Care Select Sector SPDR ETF (XLV $143.49)
- $143.49 P/E (TTM): 23.97X Cap: $37.40B
- View XLV Profile
- View Questions on XLV
-
Vanguard Health Care ETF (VHT $268.98)
- $268.98 P/E (TTM): 24.74X Cap: $17.50B
- View VHT Profile
- View Questions on VHT
Q: Looking to add a health care etf. Which one might you suggest? Would the major difference in performance between the XHC and the other 2 be the currency hedging?
Insiders
Share Information
SEC Filings
News and Media